These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 6302680

  • 1. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
    Bennett JS, Hoxie JA, Leitman SF, Vilaire G, Cines DB.
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
    [Abstract] [Full Text] [Related]

  • 2. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
    Shattil SJ, Hoxie JA, Cunningham M, Brass LF.
    J Biol Chem; 1985 Sep 15; 260(20):11107-14. PubMed ID: 2411729
    [Abstract] [Full Text] [Related]

  • 3. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS, Shattil SJ, Power JW, Gartner TK.
    J Biol Chem; 1988 Sep 15; 263(26):12948-53. PubMed ID: 3417645
    [Abstract] [Full Text] [Related]

  • 4. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H, McGregor JL.
    Eur J Biochem; 1988 Jan 15; 171(1-2):383-92. PubMed ID: 3338471
    [Abstract] [Full Text] [Related]

  • 5. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
    Coller BS, Peerschke EI, Scudder LE, Sullivan CA.
    J Clin Invest; 1983 Jul 15; 72(1):325-38. PubMed ID: 6308050
    [Abstract] [Full Text] [Related]

  • 6. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF, Liu CZ, Ouyang CH, Teng CM.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1209-19. PubMed ID: 1888330
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
    Kornecki E, Tuszynski GP, Niewiarowski S.
    J Biol Chem; 1983 Aug 10; 258(15):9349-56. PubMed ID: 6308003
    [Abstract] [Full Text] [Related]

  • 8. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS, Peerschke EI, Seligsohn U, Scudder LE, Nurden AT, Rosa JP.
    J Lab Clin Med; 1986 Apr 10; 107(4):384-92. PubMed ID: 2420911
    [Abstract] [Full Text] [Related]

  • 9. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S, Kornecki E, Hershock D, Tuszynski GP, Bennett JS, Soria C, Soria J, Dunn F, Pidard D, Kieffer N.
    J Lab Clin Med; 1985 Dec 10; 106(6):651-60. PubMed ID: 2999274
    [Abstract] [Full Text] [Related]

  • 10. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.
    McEver RP, Bennett EM, Martin MN.
    J Biol Chem; 1983 Apr 25; 258(8):5269-75. PubMed ID: 6220015
    [Abstract] [Full Text] [Related]

  • 11. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT, Hodson E, Roberts JR, Kunicki TJ, Zimmerman TS, Ruggeri ZM.
    J Clin Invest; 1985 Nov 25; 76(5):1950-8. PubMed ID: 2414325
    [Abstract] [Full Text] [Related]

  • 12. Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair.
    Di Minno G, Capitanio AM, Thiagarajan P, Martinez J, Murphy S.
    Blood; 1983 Jun 25; 61(6):1054-9. PubMed ID: 6301579
    [Abstract] [Full Text] [Related]

  • 13. Synergistic action of two murine monoclonal antibodies that inhibit ADP-induced platelet aggregation without blocking fibrinogen binding.
    Newman PJ, McEver RP, Doers MP, Kunicki TJ.
    Blood; 1987 Feb 25; 69(2):668-76. PubMed ID: 3026525
    [Abstract] [Full Text] [Related]

  • 14. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI.
    J Lab Clin Med; 1985 Aug 25; 106(2):111-22. PubMed ID: 2991399
    [Abstract] [Full Text] [Related]

  • 15. Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex.
    Brass LF, Shattil SJ, Kunicki TJ, Bennett JS.
    J Biol Chem; 1985 Jul 05; 260(13):7875-81. PubMed ID: 2409078
    [Abstract] [Full Text] [Related]

  • 16. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex.
    Di Minno G, Thiagarajan P, Perussia B, Martinez J, Shapiro S, Trinchieri G, Murphy S.
    Blood; 1983 Jan 05; 61(1):140-8. PubMed ID: 6216929
    [Abstract] [Full Text] [Related]

  • 17. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA, Albrecht RM.
    Scanning Microsc; 1987 Jun 05; 1(2):745-56. PubMed ID: 3616571
    [Abstract] [Full Text] [Related]

  • 18. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex.
    Sims PJ, Ginsberg MH, Plow EF, Shattil SJ.
    J Biol Chem; 1991 Apr 25; 266(12):7345-52. PubMed ID: 1902217
    [Abstract] [Full Text] [Related]

  • 19. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G, Cerbone A, Usberti M, Cianciaruso B, Cortese A, Farace MJ, Martinez J, Murphy S.
    J Lab Clin Med; 1986 Sep 25; 108(3):246-52. PubMed ID: 3018111
    [Abstract] [Full Text] [Related]

  • 20. Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123).
    Kornecki E, Lee H, Merlin F, Hershock D, Tuszynski GP, Niewiarowski S.
    Thromb Res; 1984 Apr 01; 34(1):35-49. PubMed ID: 6328693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.